Ironwood Pharmaceuticals Stock Forecast - Polynomial Regression

IRWD Stock  USD 3.52  0.15  4.09%   
The Polynomial Regression forecasted value of Ironwood Pharmaceuticals on the next trading day is expected to be 3.17 with a mean absolute deviation of 0.20 and the sum of the absolute errors of 12.48. Ironwood Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Ironwood Pharmaceuticals stock prices and determine the direction of Ironwood Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Ironwood Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Ironwood Pharmaceuticals' Asset Turnover is projected to increase slightly based on the last few years of reporting. . The current year's Net Income Applicable To Common Shares is expected to grow to about 211.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 137.1 M.
Ironwood Pharmaceuticals polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for Ironwood Pharmaceuticals as well as the accuracy indicators are determined from the period prices.

Ironwood Pharmaceuticals Polynomial Regression Price Forecast For the 3rd of December

Given 90 days horizon, the Polynomial Regression forecasted value of Ironwood Pharmaceuticals on the next trading day is expected to be 3.17 with a mean absolute deviation of 0.20, mean absolute percentage error of 0.07, and the sum of the absolute errors of 12.48.
Please note that although there have been many attempts to predict Ironwood Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ironwood Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ironwood Pharmaceuticals Stock Forecast Pattern

Backtest Ironwood PharmaceuticalsIronwood Pharmaceuticals Price PredictionBuy or Sell Advice 

Ironwood Pharmaceuticals Forecasted Value

In the context of forecasting Ironwood Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Ironwood Pharmaceuticals' downside and upside margins for the forecasting period are 0.04 and 7.52, respectively. We have considered Ironwood Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.52
3.17
Expected Value
7.52
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Ironwood Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Ironwood Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.421
BiasArithmetic mean of the errors None
MADMean absolute deviation0.2046
MAPEMean absolute percentage error0.0493
SAESum of the absolute errors12.4783
A single variable polynomial regression model attempts to put a curve through the Ironwood Pharmaceuticals historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for Ironwood Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ironwood Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ironwood Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.183.698.03
Details
Intrinsic
Valuation
LowRealHigh
2.336.6711.01
Details
6 Analysts
Consensus
LowTargetHigh
15.0216.5018.32
Details

Other Forecasting Options for Ironwood Pharmaceuticals

For every potential investor in Ironwood, whether a beginner or expert, Ironwood Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Ironwood Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Ironwood. Basic forecasting techniques help filter out the noise by identifying Ironwood Pharmaceuticals' price trends.

Ironwood Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ironwood Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Ironwood Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ironwood Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Ironwood Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Ironwood Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Ironwood Pharmaceuticals' current price.

Ironwood Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Ironwood Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ironwood Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ironwood Pharmaceuticals stock market strength indicators, traders can identify Ironwood Pharmaceuticals entry and exit signals to maximize returns.

Ironwood Pharmaceuticals Risk Indicators

The analysis of Ironwood Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ironwood Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ironwood stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Ironwood Pharmaceuticals to cross-verify your projections.
For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ironwood Pharmaceuticals. If investors know Ironwood will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ironwood Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Earnings Share
(0.01)
Revenue Per Share
2.393
Quarterly Revenue Growth
(0.20)
Return On Assets
0.1305
The market value of Ironwood Pharmaceuticals is measured differently than its book value, which is the value of Ironwood that is recorded on the company's balance sheet. Investors also form their own opinion of Ironwood Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ironwood Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ironwood Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ironwood Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ironwood Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.